Abbott Laboratories (ABT) stock saw a decline, ending the day at $113.86 which represents a decrease of $-0.28 or -0.25% from the prior close of $114.14. The stock opened at $114.31 and touched a low ...

Abbott Laboratories' board has raised the quarterly dividend by 7.3%, to 59 cents, making it 53 straight years that the healthcare-products company has boosted its payout. The new quarterly rate, ...

Abbott (ABT) announced that its board of directors has increased the company’s quarterly common dividend to 59c per share, an increase of 7.3%.

Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and ...

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Abbott Laboratories closed $6.14 below its 52-week high ($121.64), which the company achieved on March 8th.

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical ...

We recently compiled a list of the 8 Best Dividend Kings To Invest In For Safe Dividend Growth. In this article, we are going ...

Abbott Laboratories closed $6.74 below its 52-week high ($121.64), which the company achieved on March 8th.

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $115.6 which represents a slight increase of $0.01 or 0.01% from the prior close of $115.59. The stock opened at $115.13 and ...